atazanavir 150 mg capsule
1 INDICATIONS AND USAGE Atazanavir capsules are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at least 5 kg. Limitations of Use: Atazanavir capsules are not recommended for use in pediatric patients below the age of 3 months due to the risk of kernicterus. Use of atazanavir/ritonavir in treatment-experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions [see Microbiology ( 12.4 )] . Atazanavir capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 3 months and older weighing at least 5 kg. ( 1 )
zydus pharmaceuticals (usa) inc.
CAPSULE BLUE 1050
Related Pills
atazanavir 300 mg capsule
zydus pharmaceuticals (usa) inc.
atazanavir 200 mg capsule
zydus pharmaceuticals (usa) inc.
Esomeprazole 20 MG Delayed Release Oral Capsule
Amneal Pharmaceuticals NY LLC
esomeprazole magnesium capsule delayed release
amneal pharmaceuticals ny llc
esomeprazole magnesium 20 mg
amneal pharmaceuticals ny llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
ATAZANAVIR capsules contain
ATAZANAVIR sulfate equivalent to 150 mg of
ATAZANAVIR with off-white to light brown powder filled in size "1" empty hard gelatin capsules with opaque blue cap printed with "1050" in black ink and grey opaque body and are supplied as follows: 70710-1050-6 in bottles of 60's counts 70710-1050-1 in bottles of 100's counts
ATAZANAVIR capsules contain
ATAZANAVIR sulfate equivalent to 200 mg of
ATAZANAVIR with off-white to light brown powder filled in size "0" empty hard gelatin capsules with blue opaque cap printed with "1051" in black ink and blue opaque body and are supplied as follows: 70710-1051-6 in bottles of 60's counts 70710-1051-1 in bottles of 100's counts
ATAZANAVIR capsules contain
ATAZANAVIR sulfate equivalent to 300 mg of
ATAZANAVIR with off-white to light brown powder filled in size "00" empty hard gelatin capsules with orange opaque cap printed with "1052" in black ink and blue opaque body and are supplied as follows: 70710-1052-3 in bottles of 30's counts 70710-1052-1 in bottles of 100's counts Store
ATAZANAVIR capsules at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
More pills like CAPSULE 1050